Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Research and Innovation Action · Running

IntelliLung Intelligent Lung Support for Mechanically Ventilated Patients in the Intensive Care Unit

Coordinator
Technische Universitaet Dresden, Germany
Runs
1 September 2022 to 31 August 2027
Status
Running
EU funding
€6.0m
Total cost
€6.0m
Partners
20 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101057434

What the project is doing

In the project's own words, from its summary on CORDIS.

Invasive mechanical ventilation (MV) is one of the most important and life-saving therapies in the intensive care unit (ICU). In most severe cases, when MV alone is insufficient, extracorporeal lung support (ELS) is initiated. However, MV is recognised as potentially harmful, because inappropriate MV settings in ICU patients are associated with organ damage, contributing to disease burden. Studies revealed that MV is often not properly provided despite clear evidence and guidelines.

Furthermore, treatment decisions by the healthcare providers, especially regarding MV and ELS, often remain incomprehensible to the patients and their relatives, since flow of information from caregivers to patients is challenged by a number of factors, including limited time and resources, communication problems as well as patients? capacity to comprehend and memorise information. The project proposed herein aims at clinically validating and extending our IntelliLung Artificial Intelligence Decision Support System (AI-DSS) designed to optimise MV and ELS settings to improve the care of ICU patients, alongside caregiver-patient communication.

Thereby, best practice evidence-based MV and ELS within safer therapy corridors for longer periods, faster weaning from MV, and improved survival could be achieved - even in non-experienced hands. Additionally, this project will improve the information flow from caregivers to patients and relatives in the ICU setting. Therefore, we will develop a digital solution that allows automatic generation of an extensive plain-language information package for patients and their relatives, communicating highly individualised information on diseases and knowledge-based disease-management strategies, thus facilitating high-quality current and subsequent care through health literacy empowerment and patient-centredness.

We will perform a retrospective and prospective multi-centre study to validate our IntelliLung AI-DSS and the patient information software.

Topics

Who is involved

OrganisationCityCountryRole
Technische Universitaet DresdenDresdenGermanyCoordinator
European Society of Anaesthesiology and Intensive Care AisblBruxelles / BrusselBelgiumParticipant
Insel Gruppe AGBernSwitzerlandAssociatedpartner
Institut Fur Angewandte Informatik (infai) eVLeipzigGermanyParticipant
Was Hab' Ich? Gemeinnutzige GmbHDresdenGermanyParticipant
Better Care SLSabadellSpainParticipant
Corporacio Sanitaria Parc Tauli De SabadellSabadellSpainThird party
Fundacio Institut D'investigació I Innovació Parc TauliSabadellSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La PrincesaMadridSpainThird party
Fundacion Publica Andaluza Progreso Y Salud M.p.SevillaSpainParticipant
Servicio Madrileno De SaludMadridSpainParticipant
Irccs Azienda Ospedaliera MetropolitanaGenovaItalyThird party
Universita Degli Studi Di GenovaGenovaItalyParticipant
Demcon Innovation & Technology B.v.EnschedeNetherlandsThird party
Demcon Life Sciences & Healtheindhoven B.v.BestNetherlandsThird party
Demcon Macawi Respiratory Systems BVEnschedeNetherlandsParticipant
Demcon Life Sciences & Health Maastricht B.V.EnschedeNetherlandsThird party
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I AdministracjiWarszawaPolandParticipant
Institut Mihajlo PupinBeogradSerbiaParticipant
The Cleveland Clinic FoundationClevelandUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI